Technical Analysis for ESPR - Esperion Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 39.38 0.92% 0.36
ESPR closed down 1.76 percent on Tuesday, October 22, 2019, on 81 percent of normal volume.

Earnings due: Nov 6

*** please verify all earnings dates ***
3 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ESPR trend table...

Date Alert Name Type % Chg
Stochastic Sell Signal Bearish 0.92%
Multiple of Ten Bearish Other 0.92%
Outside Day Range Expansion 0.92%
Overbought Stochastic Strength 0.92%
NR7 Range Contraction -0.86%
Stochastic Reached Overbought Strength -0.86%
Upper Bollinger Band Walk Strength -0.86%
Overbought Stochastic Strength -0.86%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.61%
Upper Bollinger Band Walk Strength 0.61%

Older signals for ESPR ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
ESPR Chart by TradingView
Basic chart:
Profile
Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of therapies for the treatment of patients with low-density lipoprotein cholesterol and other cardiometabolic risk factors. Its products include ETC-1002, an oral molecule therapy that is in Phase IIa clinical trials to treat lipid and carbohydrate metabolic pathways; ESP41091, which is in pre-clinical trials for type 2 diabetes and obesity treatment; and 4WF, a synthetic therapy that is in pre-clinical trials to reverse the deleterious effects of atherosclerosis. The company is based in Plymouth, Michigan.
Biopharmaceutical Medical Specialties Diabetes Obesity Cardiology Cholesterol Gabaa Receptor Positive Allosteric Modulators Low Density Lipoprotein Lipids Lipoproteins Atherosclerosis
Is ESPR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Oct 4 Here's Why We're Not At All Concerned With Esperion Therapeutics's (NASDAQ:ESPR) Cash Burn Situation
Oct 4 Esperion Therapeutics: Low Risk And Primed For Substantial Growth
Sep 16 Stifel cuts view on Aurora Cannabis to Sell in premarket analyst action
Sep 9 7 Micro-Cap and Small-Cap Stocks That Insiders Are Buying
Sep 7 Esperion Therapeutics (ESPR) Down 10.8% Since Last Earnings Report: Can It Rebound?
Sep 6 Esperion Therapeutics Inc (ESPR) President & CEO Timothy M Mayleben Bought $259,125 of Shares
Aug 30 Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Aug 30 Esperion's Bempedoic Acid Succeeds in Phase II Diabetes Study
Aug 29 23 Healthcare Stocks Moving In Thursday's Pre-Market Session
Aug 29 Esperion's bempedoic acid successful in mid-stage study in type 2 diabetics with high cholesterol
See more ESPR news...
Indicators
Indicator Value
52 Week High 60.99
52 Week Low 33.13
Average Volume 357,027
200-Day Moving Average 43.3074
50-Day Moving Average 37.176
20-Day Moving Average 37.7615
10-Day Moving Average 38.456
Average True Range 1.4196
ADX 18.06
+DI 23.0842
-DI 13.4958
Chandelier Exit (Long, 3 ATRs ) 36.0712
Chandelier Exit (Short, 3 ATRs ) 39.4988
Upper Bollinger Band 40.1363
Lower Bollinger Band 35.3867
Percent B (%b) 0.76
BandWidth 12.57789
MACD Line 0.5859
MACD Signal Line 0.3226
MACD Histogram 0.2633
Fundamentals Value
Market Cap 883.25 Million
Num Shares 22.6 Million
EPS -5.77
Price-to-Earnings (P/E) Ratio -6.76
Price-to-Sales 0.00
Price-to-Book 6.37
PEG Ratio -4.32
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 40.78
Resistance 3 (R3) 40.94 40.52 40.48
Resistance 2 (R2) 40.52 40.07 40.44 40.38
Resistance 1 (R1) 39.77 39.80 39.56 39.61 40.29
Pivot Point 39.35 39.35 39.25 39.27 39.35
Support 1 (S1) 38.60 38.90 38.39 38.44 37.75
Support 2 (S2) 38.18 38.63 38.10 37.66
Support 3 (S3) 37.43 38.18 37.56
Support 4 (S4) 37.27